These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38787552)

  • 1. Monoclonal Antibody Protected Majority of Children From Malaria.
    Harris E
    JAMA; 2024 Jun; 331(23):1983. PubMed ID: 38787552
    [No Abstract]   [Full Text] [Related]  

  • 2. Sterile protection against malaria in humans with a monoclonal antibody.
    Dobaño C; Moncunill G
    Med; 2021 Nov; 2(11):1198-1200. PubMed ID: 35590195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The history of the RTS,S/AS01 malaria vaccine trial.
    Keating C
    Lancet; 2020 Apr; 395(10233):1336-1337. PubMed ID: 32334695
    [No Abstract]   [Full Text] [Related]  

  • 4. Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania.
    Tediosi F; Hutton G; Maire N; Smith TA; Ross A; Tanner M
    Am J Trop Med Hyg; 2006 Aug; 75(2 Suppl):131-43. PubMed ID: 16931824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.
    Lyke KE; Berry AA; Mason K; Idris AH; O'Callahan M; Happe M; Strom L; Berkowitz NM; Guech M; Hu Z; Castro M; Basappa M; Wang L; Low K; Holman LA; Mendoza F; Gordon IJ; Plummer SH; Trofymenko O; Strauss KS; Joshi S; Shrestha B; Adams M; Chagas AC; Murphy JR; Stein J; Hickman S; McDougal A; Lin B; Narpala SR; Vazquez S; Serebryannyy L; McDermott A; Gaudinski MR; Capparelli EV; Coates EE; Wu RL; Ledgerwood JE; Dropulic LK; Seder RA;
    Lancet Infect Dis; 2023 May; 23(5):578-588. PubMed ID: 36708738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced purchase commitments for a malaria vaccine.
    Natl Bur Econ Res Bull Aging Health; 2005; (12):1-2. PubMed ID: 16175672
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2007 Jul; 2003(4):CD000129. PubMed ID: 17636596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria battle boost.
    Williams N
    Curr Biol; 2008 Oct; 18(20):R936-7. PubMed ID: 18983950
    [No Abstract]   [Full Text] [Related]  

  • 10. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.
    Penny MA; Verity R; Bever CA; Sauboin C; Galactionova K; Flasche S; White MT; Wenger EA; Van de Velde N; Pemberton-Ross P; Griffin JT; Smith TA; Eckhoff PA; Muhib F; Jit M; Ghani AC
    Lancet; 2016 Jan; 387(10016):367-375. PubMed ID: 26549466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa.
    Galactionova K; Tediosi F; Camponovo F; Smith TA; Gething PW; Penny MA
    Vaccine; 2017 Jan; 35(1):53-60. PubMed ID: 27890400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Quest for Transformative Tools to Eradicate Malaria.
    Mundel T
    N Engl J Med; 2024 May; 390(17):1620-1621. PubMed ID: 38669440
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccines and monoclonal antibodies: new tools for malaria control.
    Miura K; Flores-Garcia Y; Long CA; Zavala F
    Clin Microbiol Rev; 2024 Jun; 37(2):e0007123. PubMed ID: 38656211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betting on a malaria vaccine.
    Okie S
    N Engl J Med; 2005 Nov; 353(18):1877-81. PubMed ID: 16267316
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrating vaccines and monoclonal antibodies into malaria prevention.
    Taylor TE; Osier F
    Nat Med; 2024 Jan; 30(1):37-38. PubMed ID: 38200257
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody acts like short-term malaria vaccine.
    Cohen J
    Science; 2021 Aug; 373(6557):843. PubMed ID: 34413219
    [No Abstract]   [Full Text] [Related]  

  • 17. Simulating the impact of malaria vaccination: what has been learnt?
    Smith T; Tediosi F
    Expert Rev Vaccines; 2012 Jul; 11(7):751-3. PubMed ID: 22913250
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP).
    Parums DV
    Med Sci Monit; 2021 Sep; 27():e934676. PubMed ID: 34511592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.
    Schmit N; Topazian HM; Natama HM; Bellamy D; Traoré O; Somé MA; Rouamba T; Tahita MC; Bonko MDA; Sourabié A; Sorgho H; Stockdale L; Provstgaard-Morys S; Aboagye J; Woods D; Rapi K; Datoo MS; Lopez FR; Charles GD; McCain K; Ouedraogo JB; Hamaluba M; Olotu A; Dicko A; Tinto H; Hill AVS; Ewer KJ; Ghani AC; Winskill P
    Lancet Infect Dis; 2024 May; 24(5):465-475. PubMed ID: 38342107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards the development of malaria vaccines.
    Malkin E; Dubovsky F; Moree M
    Trends Parasitol; 2006 Jul; 22(7):292-5. PubMed ID: 16707275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.